Analog Devices, Inc. (ADI) is working with LifeQ to develop technology that will make it possible for non-invasive body monitoring devices to provide accurate physiological data that currently is only available through the use of expensive, invasive and hard-to-access equipment.
The two companies plan to design sensors that enable personalized, continuous and accurate tracking of physiological parameters such as heart rate, sleep phases, sleep quality, blood lactate, 24-hour calorie intake as well as stress markers such as salivary cortisol. Monitoring this type of data can increase early detection of emergency conditions and diseases in at-risk patients.
The two companies plan to design sensors that enable personalized, continuous and accurate tracking of physiological parameters.“LifeQ’s collaboration with ADI will enable sensor solutions that meet a higher and wider standard, including new industry benchmarks such as the latest Android Wear requirements,” said Riaan Conradie, co-founder and chief operating officer of LifeQ, said in a statement. “Our goal is to deliver high-value physiological data to ecosystem partners who are serving consumer lifestyle, corporate wellness and health insurance markets.”
ADI’s portfolio of linear, mixed-signal, MEMS (microelectromechanical systems) and digital processing technologies are used in healthcare diagnostics, clinical monitoring equipment, life science and medical instrumentation, and health and wellness device designs.
LifeQ, on the other hand, has a computational systems biology expertise that ensures a unique approach to the construction and acquisition of information from bio-sensors. Combined with the patented LifeQ bio-mathematical engine, a range of physiological measures that are currently inaccessible, costly and invasive are now available both through wearable devices and via LifeQ’s API.